Graham S Taylor

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. Taylor G, Long H, Brooks J, Rickinson A, Hislop A. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787-821 pubmed publisher
    ..By contrast, a range of other EBV-positive malignancies of lymphoid or epithelial origin arise in individuals with seemingly intact immune systems through mechanisms that remain to be understood. ..
  2. Taylor G, Steven N. Therapeutic vaccination strategies to treat nasopharyngeal carcinoma. Chin Clin Oncol. 2016;5:23 pubmed publisher
    ..A safe therapeutic vaccine that was also able to be mass produced could, in principle, be used to vaccinate large numbers of patients after first line therapy to reduce recurrence. ..

Detail Information

Publications2

  1. Taylor G, Long H, Brooks J, Rickinson A, Hislop A. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787-821 pubmed publisher
    ..By contrast, a range of other EBV-positive malignancies of lymphoid or epithelial origin arise in individuals with seemingly intact immune systems through mechanisms that remain to be understood. ..
  2. Taylor G, Steven N. Therapeutic vaccination strategies to treat nasopharyngeal carcinoma. Chin Clin Oncol. 2016;5:23 pubmed publisher
    ..A safe therapeutic vaccine that was also able to be mass produced could, in principle, be used to vaccinate large numbers of patients after first line therapy to reduce recurrence. ..